Vos, D., Stam, A., Gruijl, T. d., Tol, P. v. d., Lougheed, S., Bakker, J., . . . Meijerink, M. Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: The CROSSFIRE trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationVos, Danielle, et al. Systemic Immunomodulation by Irreversible Electroporation Versus Stereotactic Ablative Body Radiotherapy in Locally Advanced Pancreatic Cancer: The CROSSFIRE Trial. BMJ Publishing Group.
MLA (9th ed.) CitationVos, Danielle, et al. Systemic Immunomodulation by Irreversible Electroporation Versus Stereotactic Ablative Body Radiotherapy in Locally Advanced Pancreatic Cancer: The CROSSFIRE Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.